Navigation Links
MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results
Date:12/13/2007

VANCOUVER and SAN DIEGO, Dec. 13 /PRNewswire-FirstCall/ - MIGENIX Inc. (TSX: MGI; OTC: MGIFF), a clinical-stage developer of drugs for infectious diseases, reports financial results for the three months ended October 31, 2007 and an update on its programs.

UPDATE ON DRUG DEVELOPMENT PROGRAMS

Omiganan 1% gel (Omigard(TM)/CPI-226/MX-226; topical cationic peptide; prevention of catheter-related infections): A pivotal Phase III study being conducted by our development and commercialization partner Cadence Pharmaceuticals is in progress in the United States under a Special Protocol Assessment (SPA) agreement with the US FDA and in Europe. This confirmatory Phase III trial is a randomized, Evaluation Committee-blinded study to assess the effectiveness of Omigard(TM) vs. 10% povidone-iodine for the prevention of central venous catheter-related infections. This ongoing trial is known as the Central Line Infection Reduction Study, or CLIRS trial. Cadence expects they will complete enrollment of the 1,850 patients planned for the trial in the second quarter of 2008, with results available in the second half of 2008. If the results of the CLIRS trial are positive, Cadence expects to submit a New Drug Application ("NDA") for omiganan 1% gel in the first half of 2009.

Celgosivir (MX-3253; oral alpha-glucosidase I inhibitor; treatment of chronic hepatitis C virus infections): Final top-line results of a Phase II 12-week combination therapy study in non-responder and partial responder patients were announced April 11, 2007, demonstrating proof-of-concept and evidence of clinical benefit when adding celgosivir to the current standard-of-care HCV therapy (pegylated interferon plus ribavirin) as compared to the active control treatment (standard-of-care alone) in patients with chronic hepatitis C virus genotype 1 infections who were characterized as non-responders to prior therapy with optimized pegylated alpha interferon plus ribavirin.

In conjunct
'/>"/>

SOURCE MIGENIX Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. MIGENIX First Fiscal Quarter 2008 Financial Results Conference Call & Webcast Notification
2. MIGENIX to Present Positive Celgosivir Viral Resistance Data at International HCV Meeting
3. MIGENIX Reports First Quarter Fiscal Year 2008 Financial Results
4. MIGENIX to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
5. MIGENIX Second Fiscal Quarter 2008 Financial Results Conference Call & Webcast Notification
6. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
7. QMed, Inc. Reports July Medicare SNP Enrollments
8. Phlo Affiliate Reports Expanded Coverage to Oregon Border
9. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
10. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
11. Carrington Reports Second Quarter 2007 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...e-Asia/--NODPharmaceuticalsInc.announced,theUSPate...icationfor,itsnano-particleoraldeliveryorNODtechno...chtoincorporatepeptidesor,proteinsintobio-adhesive...eadministeredasinjections.NODtechnologyisaplatform...gssuchasinsulin,interferon,growthhormone,exenatid...
(Date:11/24/2009)... recently approved the Promega PowerPlex 16 HS Sys...nerating DNA records for the National DNA Index Sy...PRWEB) -- The FBI recently approved the Promega P...s participating in, or generating DNA records for,...tly contains more than seven million profiles and ...
(Date:11/24/2009)...wswire-FirstCall/--ArenaPharmaceuticals,Inc.(Nasda...topresentatthePiperJaffray21stAnnualHealthCareConf....m.PacificTime)attheNewYorkPalaceHotelinNewYorkCit...cer,isscheduledtoprovideanoverviewofthecompany,inc...,, Aliveaudiowebcastofthepresentationwillbeavai...
(Date:11/24/2009)...l Abstracts Service (CAS), the global expert on ch...fice is now the world,s leading producer of patent...d Japan,s patent office, the World Intellectual Pr...Patent and Trademark Office (USPTO) for more than ...06, and exceeded Japan for the first time on a mon...
Breaking Biology Technology:NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3
...l implants placed will use guided surgery ...up, WALTHAM, Mass., May 6 According to Millenniu...2008 report, the incorporation of,guided surgery t...ease,dramatically over the next few years and by 2...e advantage of some form of guided surgery,technol...
...h Programs Supported by a Grant from Otsuka ...VILLE, Md., May 6 The American Psychiatric,Founda... and one individual,as the recipients of the fifth...ealth. The awards were presented at the 2008 APF A...n or individual was presented a plaque,along with ...
...rex, Inc. (Nasdaq:,MEDX) announced today that it i... Healthcare Conference at 1:00 p.m. EDT on Tuesday...will be available in the Investor,Relations sectio...m . An archived,edition of the presentation will b... Medarex is a biopharmaceutical company focused on...
Other Biology Technology:Guided Surgery Technology Gaining Popularity in the Dental Implant Market 2American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 2American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 3American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 4American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 5
(Date:11/24/2009)... a remarkable class of ring-shaped protein motors ...e Berkeley National Laboratory (Berkeley Lab) usin...ine at the Advanced Light Source (ALS). These prot...nd replication, and are vital to the survival of a... such as the human papillomavirus, which has been ...
(Date:11/24/2009)...d is a matter of debate. A high-profile study a fe...ent of their carbon from trees and leaves, evidenc...d aquatic ecosystems. , But new research from th...y to be true. Algae provide a much richer diet for...h published this week in the Proceedings of the N...
(Date:11/23/2009)...unity-associated strain of the deadly superbug MRS...ommon antibioticsposes a far greater health threat...hospitals, according to a study in the December is...w threat is easily picked up in fitness centers, s...the overall burden of MRSA within hospitals, the r...
Breaking Biology News(10 mins):Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3New study finds MRSA on the rise in hospital outpatients 2Alexza Announces Agreement to Acquire Symphony Allegro Including All Rights to AZ 004 AZ 104 and AZ 002 48973 1Alexza Announces Agreement to Acquire Symphony Allegro Including All Rights to AZ 004 AZ 104 and AZ 002 48973 2Alexza Announces Agreement to Acquire Symphony Allegro Including All Rights to AZ 004 AZ 104 and AZ 002 48973 3Alexza Announces Agreement to Acquire Symphony Allegro Including All Rights to AZ 004 AZ 104 and AZ 002 48973 4Alexza Announces Agreement to Acquire Symphony Allegro Including All Rights to AZ 004 AZ 104 and AZ 002 48973 5Alexza Announces Agreement to Acquire Symphony Allegro Including All Rights to AZ 004 AZ 104 and AZ 002 48973 6Statement of James P Firman President and CEO National Council on Aging on World Elder Abuse Awareness Day June 15 2009 48968 1Statement of James P Firman President and CEO National Council on Aging on World Elder Abuse Awareness Day June 15 2009 48968 2Canadian synchrotron conference sheds light on new biomedical research 8846 1
...-- Investigators at Burnham Institute for Medical ...age of the total protein complement (proteome) in ...east. , Laurence Brill, Khatereh Motamedchaboki, ...veloped the novel method, used to identify 4,600 p...icated techniques. The research was published onli...
...ecently sent to President Obama, more than 200 org...ientific and higher education communities, lauded ...vancing scientific research, innovation, and scien...Dear Mr. President: , On behalf of the nation,s ...ties, we wish to commend you and your Administrati...
...ntists at Albert Einstein College of Medicine of Y...e, and highly sensitive test to detect and quantif...use as a bioterrorism agent. The report appears as...alytical Chemistry . , Ricin, a protein extracted..., mist, pellet or solution. When injected or inhal...
Other Biology News:Business, scientific, higher education groups laud President Obama's commitment to science 2Einstein researchers devise a fast and sensitive way to detect ricin 2
Distillation Hood from Terra Universal, Inc.
Plastic Glove Boxes from Terra Universal, Inc.
...the professional, student, or faculty researcher, ...accelerate your research and improve the quality o...is the edge that researchers using LI-COR DNA anal...4300 System is a third generation instrument based...
Pharmaceutical Compounding Chamber from Terra Universal, Inc.
Biology Products: